Wakamoto Pharmaceutical Co.,Ltd. is engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan. It operates through four segments: Pharmaceutical Business, Healthcare Business, Global Business, and Real Estate Leasing Business. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation, as well as Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
Frequently asked questions
What sector does Wakamoto Pharmaceutical Co Ltd (4512) operate in?
Wakamoto Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Wakamoto Pharmaceutical Co Ltd (4512) current stock price?
As of the latest data, Wakamoto Pharmaceutical Co Ltd stock price is ¥295, with a previous close of ¥294. Wakamoto Pharmaceutical Co Ltd gained ¥1 in the last trading session, representing a 0.34% increase.
What is Wakamoto Pharmaceutical Co Ltd (4512) current market capitalization?
Wakamoto Pharmaceutical Co Ltd market cap is approximately 10.24 billion.
What is Wakamoto Pharmaceutical Co Ltd (4512) Earnings Per Share (EPS)?
The trailing EPS is ¥7.
What is Wakamoto Pharmaceutical Co Ltd (4512) Price-to-Earnings (P/E) ratio?
Wakamoto Pharmaceutical Co Ltd current P/E ratio is 45.04.
What is Wakamoto Pharmaceutical Co Ltd (4512) EBITDA?
Wakamoto Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -6.37 million.
Does Wakamoto Pharmaceutical Co Ltd (4512) pay dividends?
Yes. Wakamoto Pharmaceutical Co Ltd pays annual dividends with an annualized yield of 1.19% and an estimated annual payout of ¥4 per share.
When is the next ex-dividend date for Wakamoto Pharmaceutical Co Ltd (4512)?
The next ex-dividend date is scheduled for March 30, 2027.
What is Wakamoto Pharmaceutical Co Ltd (4512) beta (volatility) score?
Wakamoto Pharmaceutical Co Ltd has a beta of 0.449, indicating lower volatility than the overall market.
